{"altmetric_id":21733020,"counts":{"readers":{"mendeley":3,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4fa3cf058f610003008","authors":["A Gratwohl","H Baldomero","A Schwendener","M Gratwohl","A Urbano-Ispizua","K Frauendorfer"],"doi":"10.1038\/sj.leu.2404509","endpage":"386","first_seen_on":"2017-07-10T16:27:00+00:00","issns":["0887-6924","1476-5551"],"journal":"Leukemia (08876924)","last_mentioned_on":1486401627,"links":["http:\/\/dx.doi.org\/10.1038\/sj.leu.2404509"],"pmid":"17311065","pubdate":"2007-03-01T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"383","subjects":["neoplasms","hematology"],"title":"Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe\u2014Impact of cost considerations","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/hematopoietic-stem-cell-transplants-chronic-myeloid-leukemia-europeimpact-cost-considerations-1"},"altmetric_score":{"score":3,"score_history":{"1y":3,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":8170298,"mean":6.9145785001388,"rank":2065648,"this_scored_higher_than_pct":61,"this_scored_higher_than":4986146,"rank_type":"exact","sample_size":8170298,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":168705,"mean":11.310313163885,"rank":53252,"this_scored_higher_than_pct":67,"this_scored_higher_than":113843,"rank_type":"exact","sample_size":168705,"percentile":67},"this_journal":{"total_number_of_other_articles":1832,"mean":5.276083014746,"rank":627,"this_scored_higher_than_pct":52,"this_scored_higher_than":958,"rank_type":"exact","sample_size":1832,"percentile":52},"similar_age_this_journal_3m":{"total_number_of_other_articles":72,"mean":5.3559718309859,"rank":37,"this_scored_higher_than_pct":48,"this_scored_higher_than":35,"rank_type":"exact","sample_size":72,"percentile":48}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":1,"Student  > Bachelor":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":3}}}},"posts":{"policy":[{"title":"Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia: Committee papers","url":"https:\/\/www.nice.org.uk\/guidance\/ta451\/documents\/committee-papers","license":"public","citation_ids":[1587536,20457202,15785139,5867949,9707176,11846581,1876210,2088873,6080039,736875,3563133,210423,6289997,1383325,21732871,6288019,210500,15788656,6380409,5753995,7263003,21732886,21732889,21732890,21732894,21732896,2415481,21732898,1145378,8858075,21732900,21732905,21732907,21732913,5318109,8858072,21732920,21732925,21732926,8858604,7404750,3021268,6078602,5532901,21732937,6074178,21732944,21732947,21732951,21732952,21732957,17975697,15786570,17923897,3710340,15783853,3815443,21732963,1756101,5753993,21732968,15781531,2316530,21732971,781398,230981,230562,4245553,7338934,21732983,629223,21732986,21732988,21444444,3969843,7629958,17984330,21732992,641462,1111328,21732995,15534708,8254988,6080248,1497631,525517,17909608,17909407,21444601,21733007,19906125,21733010,6079588,2177297,6288476,8150525,2414789,522727,6114930,1137561,437219,21733019,21733020,2279906,21733025,17989590,6114925,17975599,6087639,6080142,21733045,21733048,3281293,21733051,1084279,21733054,4552991,21733058,4761276,5634071,487885,171139,431729,6079556,129312,1317846,20904208,3245828,3252986,1784115,1176058,17902250,17930565,4841033,21733075,247134,21733081,21733085,1095466,15783873,10181835,1094858,21733097,17930924,3679455,21733098,3005016,545798,21733101,5100696,4686093,5100696,21733104,21733106,20309623],"posted_on":"2017-02-06T17:20:27+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/ta451\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-383a09706d82cf95a3fa61456eb94bf9167b2dada8027b607e1d247b5ae986c9.jpg"}}]}}